000027996 000__ 02759cam\a2200541\i\4500 000027996 001__ 27996 000027996 003__ SzGeWIPO 000027996 005__ 20230626113429.0 000027996 006__ m\\\\eo\\d\\\\\\\\ 000027996 007__ cr bn |||m|||a 000027996 008__ 180123s2017 enk o ||| 0 eng d 000027996 020__ $$a9781138934481 000027996 020__ $$a9781317389781$$qe-book 000027996 035__ $$a(OCoLC)973836406 000027996 035__ $$a(wipo)EBC4809686 000027996 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000027996 041__ $$aeng 000027996 050_4 $$aK1519.D78.C66 2016 000027996 08204 $$a346.0486$$220 000027996 1001_ $$aMercurio, Bryan., 000027996 24510 $$aContemporary Issues in Pharmaceutical Patent Law :$$bSetting the Framework and Exploring Policy Options. 000027996 264_1 $$aLondon :$$bTaylor and Francis,$$c2017. 000027996 300__ $$a1 online resource (258 pages). 000027996 336__ $$atext$$2rdacontent 000027996 337__ $$acomputer$$2rdamedia 000027996 338__ $$aonline resource$$bcr$$2rdacarrier 000027996 4901_ $$aRoutledge Research in Intellectual Property 000027996 5050_ $$aCover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- Notes on Contributors -- 1 Introduction: A Holistic Approach to Pharmaceutical Patent Law and Policy -- Part I Pharmaceutical Patents and Related Types of Protection -- 2 Patentability of Pharmaceutical Inventions under TRIPS: Domestic Court Practice Testing International Policy Space -- 3 Biologics, Biosimilars and Other Idiosyncrasies -- 4 Index of Data Exclusivity and Access (IDEAS): An Analysis of Test Data Exclusivity Provisions in Free Trade Agreements and National Laws -- 5 Patent Linkage Regulations: The Importance of Context and of Balancing Competing Interests -- Part II Balancing Patent Protection with Available Flexibilities -- 6 The Bolar Exception: Legislative Models and Drafting Options -- 7 Compulsory Licensing: Threats, Use and Recent Trends -- 8 A Manufacturing for Export Exception -- Part III A Broader View on Incentives for Pharmaceutical Innovation -- 9 The Price of Exclusivity: The Economics of Patent Extensions and Data Protection -- 10 Rationalizing Innovation Incentives under Drug Approval Regulation: National Policy Perspective -- 11 The Trans-Pacific Partnership Agreement and Its Implications for Access to Medicine -- Index. 000027996 588__ $$aDescription based on publisher supplied metadata and other sources. 000027996 590__ $$aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2018. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. 000027996 650_0 $$aDrugs. 000027996 650_0 $$aPatents. 000027996 650_0 $$aIntellectual property. 000027996 650_0 $$aCopyright. 000027996 655_4 $$aElectronic books. 000027996 7001_ $$aKim, Daria. 000027996 77608 $$iPrint version:$$aMercurio, Bryan$$tContemporary Issues in Pharmaceutical Patent Law : Setting the Framework and Exploring Policy Options$$dLondon : Taylor and Francis,c2017$$z9781138934481 000027996 7972_ $$aProQuest (Firm) 000027996 830_0 $$aRoutledge Research in Intellectual Property. 000027996 85640 $$uhttps://ebookcentral.proquest.com/lib/wipo/detail.action?docID=4809686$$zView this Ebook 000027996 904__ $$aBook 000027996 942__ $$cEBOOK 000027996 980__ $$aBIB 000027996 980__ $$aEBL_old 000027996 980__ $$aOS 000027996 999__ $$c30700$$d30700